Despite the tremendous potential of adenovirus (Ad) as a delivery vector for cancer gene therapy, its use in clinical settings has been limited, mainly as a result of the limited infectivity in many tumors and the wide tissue tropism associated with Ad. To modify the tropism of the virus, we have inserted the epidermal growth factor-like domain of the human heregulin-a (HRG) into the HI loop of Ad5 fiber. This insertion had no adverse effect on fiber trimerization nor did it affect incorporation of the modified fiber into infectious viral particles. Virions bearing modified fiber displayed growth characteristics and viral yields indistinguishable from those of wild-type (wt) virus. Most importantly, HRG-tagged virions showed enhanced infection of cells expressing the cognate receptors HER3/ErbB3 and HER4/ErbB4. This was significantly reduced in the presence of soluble HRG. Furthermore, HER3-expressing Chinese hamster ovary (CHO) cells were transduced by the HRG-modified virus, but not by wt virus. In contrast, CHO cells expressing the coxsackie-Ad receptor were transduced with both viruses. However, infection of an in vivo breast cancer xenograft model after intratumoral injection was similar with both viruses, suggesting that the tumor microenvironment and/or the route of delivery have important roles in infection of target cells with fiber-modified Ads.
INTRODUCTION
Research during the past two decades has underscored the potential of adenoviruses (Ads) as gene delivery vehicles, 1 and more recently as commercialized cancer gene therapeutics in China. 2, 3 In addition to being among the most extensively studied viral vectors, Ads can be easily and economically manipulated, maintained and propagated to produce high titer stocks. 4, 5 Moreover, they have the capacity to carry relatively large fragments of exogenous DNA into a wide range of cell and tissue types. 4, 5 Subgroup C Ads (exemplified by the most widely used Ad5 and Ad2) attach to and enter host cells in a two-step process. 6 The initial recognition/attachment step is mediated by interactions between the knob component of fiber protein on the Ad capsid and the extracellular domain of the coxsackieadenovirus receptor (CAR) on the host cell surface. [7] [8] [9] [10] [11] This attachment is followed by a second interaction between the RGD motif in the penton base of the virus capsid and a v b 3 or a v b 5 cell surface integrins (secondary Ad receptors), which allows viral entry via receptor-mediated endocytosis. [12] [13] [14] [15] Both the primary and secondary Ad receptors are expressed on a wide range of tissues leading to the observed broad tissue tropism of Ads. 16, 17 Unfortunately, a large number of tumor cells appear relatively refractory to Ad infection because of limited surface expression of the primary Ad receptor. 1, [18] [19] [20] [21] [22] [23] This observation has been a driving force behind recent intensive efforts to generate Ad viral vectors with altered tropism.
Fiber has been a major target of most attempts to alter Ad tropism. Two common strategies for altering viral tropism have been genetic modification of the viral fiber gene and/or use of bispecific molecules that act as a bridge between the virus and a target cell surface protein. 24, 25 Ad5 fiber is a homotrimeric protein of 186 kDa that protrudes from each of the 12 vertices of the viral particle. The protein is composed of a 44-amino-acid (aa) N-terminal tail that anchors fiber to the penton base through non-covalent interactions, a 355 aa b-spiral shaft extending away from the capsid and a 181 aa globular knob domain at the extreme C terminus that is essential for trimerization. [26] [27] [28] [29] The knob domain is both necessary and sufficient for CAR binding, 7, 30 and thus is a primary target for attempts to alter tropism. Threedimensional structure analysis of the fiber knob revealed that the monomers, a sandwich of two anti-parallel b-sheets with six flexible loops connecting the b-strands, assemble into a threebladed propeller-shaped trimer. The highly flexible HI loop (connecting the H and I b-strands), oriented away from the viral particle, is not required for CAR binding and probably does not contribute to trimer assembly, making the HI loop a potential site for insertion of targeting ligands. Indeed, the utility of the HI loop as a site of ligand insertion has been successfully demonstrated for a number of small peptide targeting ligands, or larger, unstructured ligands. [31] [32] [33] [34] [35] [36] [37] To overcome suboptimal expression of CAR in cancer cells and to demonstrate the utility of the HI loop to accommodate relatively large targeting ligands, we sought to expand the viral tropism by insertion of the epidermal growth factor (EGF)-like domain of heregulin-a (HRG) into the HI loop. HRGa, also called neuregulin and Neu differentiation factor, 38, 39 binds directly via the EGF-like domain [40] [41] [42] to HER3/ErbB3 and/or HER4/ErbB4, members of the EGF receptor family, which then homodimerize or heterodimerize with HER2/ErbB2 to initiate a transmembrane signal. [43] [44] [45] [46] The moderate size (50-55 aa) and folding of the EGF-like domain of HRG [47] [48] [49] suggested that this domain could be inserted into the HI loop without affecting the integrity of fiber. Moreover, an HRG-targeted virus may be valuable for the treatment of a number of human malignancies, including breast and ovarian carcinomas, in which members of HER receptor family are frequently overexpressed. [50] [51] [52] [53] [54] In this regard, Han and co-workers 55 have demonstrated that a recombinant Moloney murine leukemia virus carrying a gp70-HRG fusion envelope protein was able to infect normally refractory human breast cancer cell lines in a receptor-dependent manner.
In this communication, we describe the construction of a replication-defective Ad5-based vector containing the HRG EGF-like domain in the HI loop of fiber knob. This modified vector propagated with characteristics similar to those of a control virus containing wild-type (wt) fiber. We show that the modified virus was more efficient than control virus in in vitro gene transfer to cells expressing the cognate receptors for HRG. Moreover, competition experiments with recombinant HRG or soluble knob clearly demonstrated that the modified virus was capable of entering cells via a novel HRG-mediated pathway in addition to the native, CAR-dependent mechanism. Addition of the HRG EGFlike domain to the virus fiber knob confers on the virus the ability to infect cell lines poorly infected by virus with native capsids, and this infectivity is at least partially dependent on HRG binding. In contrast, we did not observe a difference in gene transfer between the modified virus and the control virus following intratumoral injections in a mouse breast cancer xenograft model. We suggest that this loss of differential infectivity could be due to the high local concentrations of virus resulting from intratumoral injections. We propose that it may be possible to improve this differential by increasing virus dispersion intratumorally either by modifying virus delivery or by using conditionally replicating virus.
MATERIALS AND METHODS Cells
Cell lines are available from ATCC (Manassas, VA, USA), except where indicated. The mouse breast cancer cell line MT1A2 (derived at McMaster University, Hamilton, Ontario, Canada), 56 the human ovarian cancer cell line SKOV-3, the human glioblastoma cell line U118MG, the human rhabdomyosarcoma cell line RD and the human cervical cancer cell line HeLa were maintained in Dulbecco's modified Eagle's medium. The Chinese hamster ovary (CHO) cell lines were maintained in Dulbecco's modified Eagle's medium high glucose. The human breast cancer cell lines ZR-75-1, BT549a, BT549b, MDA-MB-361, MDA-MB-453, SK-BR-3 and T47D, as well as the lung carcinoma cell line A549, were maintained in RPMI 1640 medium (RPMI). The human breast cancer cell lines MCF-7, MDA-MB-468 and MDA-MB-231 were maintained in either Dulbecco's modified Eagle's medium or RPMI. The Ad5 E1-transformed human embryonic kidney cell line 293 57 and its derivative 293Cre4 58 were maintained in minimal essential medium. All growth media (Invitrogen, Burlington, ON, Canada) were supplemented with 10% fetal bovine serum (Sigma-Aldrich Co., St Louis, MO, USA), 2 mM L-glutamine, 100 U ml À 1 penicillin and 100 mg ml À 1 streptomycin. Insulin was also added to 5 mg ml À 1 for MCF-7 and MDA-MB-361 cultures. Cell lines were maintained in humidified 37 1C incubator with 5% CO 2 atmosphere.
CHO cells expressing CAR (CHO-CAR) and a control cell line expressing human a2 integrin (CHO-al2) were acquired from Dr J Bergelson (Children's Hospital of Philadelphia). 8 CHO-al2 was transfected with a plasmid encoding HER3 cDNA (Open Biosystems, Lafayette, CO, USA) and a hygromycin resistance gene. Stable transfectants were selected by hygromycin treatment. Individual clones were isolated by fluorescenceactivated cell sorting (BD Influx; Becton Dickinson, Franklin Lakes, NJ, USA) using an anti-HER3 antibody (phycoerythrin (PE)-conjugated anti-hErbB3; R&D Systems, Minneapolis, MN, USA). Clonal populations expressing high HER3 on 490% of cells were chosen for future experiments. CHO-NT cells are CHO cells that were not transfected with any exogenous DNA (gift from Dr Z Wang, University of Alberta, Edmonton, Alberta, Canada).
Plasmids
Fiber gene manipulations were carried out in a plasmid bearing approximately the rightmost 15% of the Ad5 genome (from position 30 429 to the end of the right inverted terminal repeat (ITR)) flanked upstream by a Lox P site. Insertion of unique XhoI and SpeI sites into the HI loop was accomplished by PCR mutagenesis, yielding the plasmid pFG23XS. The EGF-like domain of HRG was generated by DNA polymerasemediated assembly of overlapping oligonucleotides (listed in Supplementary Table 1) as described by Stemmer and co-workers. 59 The resulting product was cloned between the XhoI and SpeI sites in the HI loop coding sequence in pFG23XS to yield the plasmid pFG23XS-HI-HRG (Figure 1 ). Insertion of HRG in the HI loop resulted in substitution of residues Q 540 -P 547 of the HI loop with a 15 aa 5 0 linker, 52 aa EGF-like domain and 4 aa 3 0 linker for a total of 68 aa. All constructs were confirmed by sequencing analysis.
The plasmid pFG173LoxAmp-dE1-LucAnti ( Figure 1 ) contains viral DNA sequences from positions 1 to 28 138 of the Ad5 genome, except lacking the E1 region (456-3525). This viral sequence, terminating at the start of the E3 region (that is, excluding the E3 region), is followed by a firefly luciferase reporter expression cassette and a Lox P site. Figure S1 ). The amino-acid sequence corresponding to the epidermal growth factor (EGF)-like domain of HRGa (also called neuregulin) are in bold, the linker sequences are underlined and the amino acids between GTSH and NVP of HRG-a are represented by two dashes. The full amino-acid sequence of the insert can be found in Supplementary Figure S1 . (b) Structure of the control virus AdLuc(wt-fiber) (previously designated AdLC8c-luc 61 ). Open reading frames and regulatory sequences are indicated by broad arrows. Ad sequences are indicated by narrow black bars. Ad, adenovirus; HRG, heregulin-a; wt, wild type.
Fiber modification of adenovirus increases infection SH MacLeod et al

Construction of recombinant virus
Construction of AdLuc(HRG-fiber), carrying the HRG ligand in the HI loop, was accomplished by Cre-mediated recombination between the plasmids pFG23XS-HRG and pFG173LoxAmp-dE1-LucAnti in 293Cre4 cells (Figure 1) . Briefly, plaques were picked from monolayers of 293Cre4 cells overlaid with agarose-containing medium following co-transfection with the two plasmids. 60 The E1-deleted AdLuc(wt-fiber) (Figure 1 ), also called AdLC8c-luc, 61 contains the same reporter expression cassette in place of the E3 region as that in AdLuc(HRG-fiber). Recombinant viruses were plaque-purified, amplified in 293 cells and purified using CsCl gradient centrifugation. 60 The titer of each viral stock (in plaque-forming unit (PFU) ml À 1 ) was determined by plaque assay 60 and the concentration of viral particles (vp) was determined spectrophotometrically using the method of Maizel and co-workers. 62 Both viral stocks were subjected to DNA and fiber protein analysis to confirm their structure.
In vitro trimerization assay
Wt fiber, HRG-modified fiber and luciferase coding sequences were inserted into the NcoI site of the in vitro expression vector pSPUTK. 63 The resulting plasmids, pSP-fiber, pSP-HI-HRG and pSPluc, respectively, were translated (200 ng DNA) in 10 ml 
Immunoblots
Purified virion suspensions containing 2.5 Â 10 9 vp in SDS-PAGE sample buffer were either loaded directly onto 8% polyacrylamide gels or boiled for 5 min before loading. Following resolution, proteins were electrotransferred to polyvinylidene difluoride membranes (Millipore, Billerica, MA, USA). Blocked membranes were probed for fiber and hexon using, respectively, the anti-fiber monoclonal antibody 4D2 (Research Diagnostics Inc., Flanders, NJ, USA), which recognizes both monomer and trimer forms, and the anti-hexon 2HX2 (ATCC) hybridoma supernatant. Signals were detected using horseradish peroxidase-conjugated anti-mouse IgG antibody (Pharmingen, Franklin Lakes, NJ, USA) and ECL Western detection reagents (Amersham Bioscience, Piscataway, NJ, USA).
To detect cellular proteins, total cell lysates were prepared from washed cells by incubation on ice for 20 min in lysis buffer (50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% NP-40, 1% Triton X-100, 1% sodium deoxycholate, 1 mM phenylmethylsulfonyl fluoride and 1 mg ml À 1 of each of aprotinin, leupeptin and pepstatin). Cleared lysates were assayed for protein using a Micro-BCA kit (Pierce, Rockfort, IL, USA). In all, 50 mg total protein (100 mg for HER4 and CAR analyses) were boiled for 7 min in sample buffer before resolution by SDS-8% PAGE. Resolved proteins were electro-transferred to polyvinylidene difluoride membranes. Blocked membranes were probed for HER2, HER3, HER4 (rabbit polyclonal antibodies anti-neu, C18 (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA); anti-ErbB3, C17 (Santa Cruz Biotechnology Inc.); anti-ErbB4 (Lab Vision Corp., Kalamazoo, MI, USA), human CAR (mouse monoclonal antibody RmcB; Upstate USA Inc., Billerica, MA, USA) and b-actin (mouse monoclonal antibody AC15; Sigma-Aldrich Co.). Signals were detected using either horseradish peroxidase-conjugated anti-mouse IgG or horseradish peroxidase-conjugated anti-rabbit IgG antibody (Pharmingen) and ECL Western detection reagents (Amersham Bioscience).
Flow cytometry
Cells were trypsinized and washed with phosphate-buffered saline (PBS) before staining with antibody: mouse anti-CAR antibody (RcmB) with anti-mouse IgG (PE-conjugated; R&D Systems) as a secondary antibody, or anti-HER3 (PE-conjugated). Fluorescence was detected using FACSort (Becton Dickinson) or FACSCalibur (Becton Dickinson) flow cytometers. Gating was set such that 1% of the control sample was positive using PE-labeled secondary alone as a control for CAR, or PE-labeled mouse IgG isotype control (R&D Systems) as a control for HER3.
Reporter gene expression
Cells were seeded in 24-well culture dishes, at approximately 1 Â 10 5 cells per well, 24 h before infection at the indicated multiplicity of infection (MOI). At 24 or 48 h postinfection, cells were washed in PBS, and then lysed in Reporter Lysis Buffer (Promega). Luciferase activity was determined using a Luciferase Assay System (Promega). The total protein concentration of each sample was determined using a BCA kit (Pierce).
Competition assays
To generate soluble fiber knob protein, the sequence of Ad5 fiber corresponding to the fiber knob (lysine 398 to glutamic acid 581) was PCR-amplified and inserted into the bacterial expression plasmid pET15-b (Novagen, Darmstadt, Germany). The resulting plasmid, pET15-Ad5knob, was transferred to Escherichia coli BL21 (DE3) pLysS (Novagen). After induction with 1 mm isopropylthio-b-galactoside for 4 h at 37 1C, the protein was extracted from the cells under native conditions and purified using Ni-NTA agarose column (Qiagen, Toronto, ON, Canada). Following extensive dialysis against PBS, the protein concentration was determined using a BCA kit (Pierce).
In all, 2 mg of s-knob were added to 2 Â 10 5 cells in 24-well dishes and the cells were incubated at room temperature for 20 min. Virus was then added to the cells (100 vp per cell) and the incubation was continued for an additional 30 min at room temperature. The medium was then removed and the cells were washed twice with PBS and overlaid with complete medium. The cells were incubated for 24 h, and then luciferase activity was determined as above.
For HRG competition experiments with cancer cell lines, 2 Â 10 5 cells in 24-well plates were overlaid with cold Dulbecco's modified Eagle's medium/F12 (Invitrogen) media containing 0.25 mg of recombinant human HRGa EGF-like domain (R&D Systems) and incubated on ice for 30 min. Virus (100 vp per cell) was then added and incubation was continued for an additional 30 min on ice. The cells were then shifted to room temperature for 10 min before washing twice with PBS. Following the addition of the medium, the cells were incubated for 24 h at which time luciferase activity was determined as above. HRG competition experiments with CHO cells were carried out similarly, except that the recombinant HRGa EGF-like domain was added in PBS and the MOI was 1 PFU per cell.
Mouse tumor model
A total of 5 Â 10 5 or 2 Â 10 6 ZR75.1 human breast cancer cells were suspended in 25% Matrigel Basement Membrane Matrix (Becton Dickinson) and injected into each of the two contralateral abdominal mammary fat pads of female NIH III mice (five mice for each cell concentration). To facilitate tumor growth, 17-b-estradiol pellets (0.72 mg per pellet, 60-day release; Innovative Research of America, Sarasota, FL, USA) were implanted subcutaneously at the time of cell injection. After 40 days, the mice were separated into two groups with approximately equal tumor volumes. One tumor per mouse was injected with 3 Â 10 8 PFU of either AdLuc(HRG-fiber) or AdLuc(wt-fiber) (five mice each) three times over a 1-week period. Mice were killed 2 days after the last virus injection. Tumors and livers were harvested, flash frozen in liquid nitrogen and stored at À 80 1C. Tissues were homogenized by GentleMACS tissue dissociator (Miltenyi Biotec, Bergisch Gladbach, Germany), then protein concentration determined by BCA assay and subsequently luciferase activity assayed as above.
RESULTS
Insertion of the HRG peptide into the HI loop does not interfere with fiber trimerization Assembly of the fiber molecule into virions is dependent on its ability to form homotrimers, as only the trimer form can associate with the penton base. Therefore, we sought to ensure that insertion of the EGF-like domain of HRG into the HI loop, as described in Materials and methods, did not ablate fiber trimerization. Taking advantage of the ability of recombinant fiber protein to form stable trimers in the absence of other viral proteins, 28, 31 we employed a rabbit reticulocyte lysate-based in vitro fiber trimerization assay to assess rapidly the structural integrity of mutant fibers. In this system, the fiber (wt and HRGmodified) genes were placed under the control of the SP6 RNA polymerase promoter in a plasmid expression vector.
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Following coupled transcription/translation in the presence of [ 35 S]methionine, the products were assessed for their ability to form trimers using seminative SDS-PAGE. The results shown in Figure 2a clearly establish that wt fiber produced in rabbit reticulocyte lysate formed stable trimers (top panel, lane 2) that dissociated into monomers (62 kDa) upon boiling in SDS-sample buffer (bottom panel, lane 2). Moreover, the trimerization of the fiber was specific since an unrelated protein that is monomeric in nature, firefly luciferase (62 kDa), produced in the same system was unable to form oligomers (lane 1) under seminative conditions. In addition, the fiber molecule carrying the HRG EGF-like domain in the HI loop also formed trimers in vitro (lane 3). Furthermore, as with wt fiber, the modified trimer dissociated into monomers upon boiling (Figure 2a , bottom panel). Taken together, the data suggest that this modification of fiber may permit proper virion assembly.
Virions with HRG-modified fiber are viable The ultimate test for the functionality of modified fiber molecules is the ability to assemble into infectious virions. To this end, we set out to rescue the modified fiber molecule into virus using a two-plasmid, Cre-mediated recombination rescue system. 60 The plasmid pFG23XS, bearing the rightmost 15% of the Ad5 genome immediately downstream of a Lox P site (see Materials and methods), was engineered to contain a number of convenient unique restriction sites that allow for easy modification of the fiber gene. These unique sites facilitated insertion of the HRG peptide into the HI loop to generate pFG23XS-HI-HRG. The recombination partner, the subgenomic pFG173LoxAmp-dE1-LucAnti plasmid, contained viral sequences starting with an ITR junction, excluding the E1 region, and then continuing through to the 5 0 boundary of the E3 region (position 28 138). The inclusion of an ITR junction rather than just the left ITR was based on the finding that ITR junctions serve as highly efficient Ad origin of replication and significantly increase the efficiency of virus rescue. 65, 66 The E3 region in this plasmid was replaced by a firefly luciferase reporter cassette driven from the immediate-early (IE) promoter of the human cytomegalovirus, followed by a Lox P site. Cre-mediated recombination between the Lox P sites on both plasmids resulted in the generation of a replication-defective virus bearing the reporter cassette in place of the E3 region, and the HRG peptide inserted into the fiber. This structure was confirmed by PCR, restriction enzyme and sequence analysis of viral DNA (data not shown).
To determine if the modified fiber protein was incorporated into mature virions and to assess the virion fiber content, we carried out western blot analysis of purified AdLuc(HRG-fiber) and AdLuc(wt-fiber) virions. Approximately equal numbers of particles of the wt or modified fiber virus were either loaded directly on SDS-PAGE gels to detect fiber trimers or boiled before loading to dissociate the fiber into monomers. As expected, all wt fiber molecules associated with purified virions were in the trimer conformation under seminative conditions (unboiled lanes in Figure 2b) . More importantly, the virion-associated, HRG-modified fiber molecules were in trimer conformation as well. When boiled, both virion-associated wt and modified fiber trimers dissociated into monomers with the predicted molecular weights of 62 kDa for wt and 67.8 kDa for HRG-modified fiber (Figure 2b) . Furthermore, AdLuc(HRG-fiber) clearly displayed a complement of fiber molecules similar to that present in the AdLuc(wt-fiber) control virus, as evidenced by the similar fiber:hexon ratios. Thus, insertion of the HRG peptide into the HI loop of Ad5 fiber did not interfere with the structural integrity of the fiber molecule or assembly of the virus particle.
To study the growth characteristics of the recombinant virus relative to the control virus, parallel one-step growth curves were obtained following infection with either AdLuc(HRG-fiber) or control AdLuc(wt-fiber) virus at an MOI of 5 PFU per cell (Figure 3) . Titration of the infected cell lysates at various times postinfection showed that the growth rate of AdLuc(HRG-fiber) was indistinguishable from 
that of the control virus. Furthermore, titers of the purified viral stocks were 3.1 Â 10 10 and 1.8 Â 10 10 PFU ml À 1 , with particle:PFU ratios of 45 and 53 for AdLuc(wt-fiber) and AdLuc(HRG-fiber) stocks, respectively. Taken together, these data indicate that insertion of HRG into the HI loop of the Ad5 fiber had no detectable adverse effect on virus viability or growth.
EGF-like domain of HRG confers enhanced gene transfer efficiency in cells expressing target receptors To assess the ability of the inserted ligand to provide a CARindependent cell entry pathway, we assembled a panel of cell lines encompassing a wide range of CAR, HER2, HER3 and HER4 expression levels. These cells can be roughly divided into the following categories based on the expression of CAR and HRG receptors (HER3 and HER4) by western blot (Figure 4a ): (i) cells expressing moderate to high levels of CAR and high levels of at least one of the HRG receptors (MDA-MB-468); (ii) cells that express low or undetectable levels of CAR and high levels of at least one of the HRG receptors (MDA-MB-361, ZR-75-1, MCF-7 SKOV-3 and RD); (iii) cells that express moderate to high CAR but low levels of HRG receptors (HeLa, BT549a and MDA-MB-231); and (iv) cells that express very low or undetectable levels of both CAR and the HRG receptors (U118MG). Measuring the cell surface levels of CAR and HER3 by flow cytometry (Figure 4b ) generally agreed with the placement of cells into the categories above; however, there were a few differences in CAR levels. We detected moderate levels of CAR on MDA-MB-361 by flow cytometry, as opposed to low levels by western blot, and the reverse with MDA-MB-231 cells. In addition, two separate isolates of BT549 cells (here designated BT549a and BT549b) demonstrated different levels of CAR. These differences may be explained by the different methods used to detect the receptors, or differences in expression levels at the time of measurement. Thus, we used the receptor levels measured at the time of each infection to categorize the cell lines. Additional cell lines categorized by flow cytometry include: (i) T47D; (ii) A549, MDA-MB-453, SK-BR-3 and CHO-al2/HER3; (iii) 293 and CHO-CAR; and (iv) BT549b and CHO-al2.
The efficiency of infection of cell lines analyzed by western blot was assessed by examining luciferase reporter gene expression following infection with either the modified AdLuc(HRG-fiber) virus or the control AdLuc(wt-fiber) virus (Figure 5a ). As expected, AdLuc(wt-fiber) infection of cell lines with very low levels of CAR (for example, MCF-7) resulted in very low absolute levels of reporter gene expression. However, some cell lines expressing high levels of CAR did not show high infectivity (for example, of cancer lines, MDA-MB-468 showed the highest level of CAR, but relatively low levels of reporter expression), suggesting that other factors involved in Ad entry (for example, the secondary receptors a v b 3 and a v b 5 integrins), nuclear localization, CMV promoter activity and/or other processes can also contribute to transgene activity. The influence of these variable factors on interpretation of results was minimized by directly comparing luciferase expression after AdLuc(HRG-fiber) infection to that after AdLuc(wt-fiber) infection for each cell line. An increase in luciferase expression was seen after AdLuc(HRG-fiber) infection relative to AdLuc(wt-fiber) infection in all cell lines that express high levels of the HRG receptors HER3/4 (categories (i) and (ii)). This increase was statistically significant in all but the mouse cell line MT1A2, which was poorly infected by both viruses. In contrast, for three of the four cell lines that have no or low HER3/4 (categories (iii) and (iv)), there was no statistical difference between reporter expression in infections with the two viruses. It is possible that the low but detectable level of HER3 expressed in the fourth cell line of this group (MDA-MB-231) was sufficient to increase infectivity by AdLuc(HRG-fiber). The level of HER2 in our panel of cells did not seem to have either a positive or negative impact on reporter gene expression. These results are consistent with the hypothesis that HER3 and/or HER4 mediate uptake of the HRG-modified fiber virus.
Further analysis of infectivity of ZR-75-1 (high HER3 and low CAR) and BT549b (low HER3 and low CAR) demonstrated a linear dose response with both viruses up to an MOI of 50 PFU per cell (Figure 5b ). Luciferase expression in ZR-75-1 infected with AdLuc(HRG-fiber) was significantly higher than that in all other infections in this experiment at all MOIs (Po0.01, analysis of variance (ANOVA)). In contrast, the difference in infectivity of HER3-low BT549b cells by the two viruses was statistically significant (Po0.05, ANOVA) only at MOIs 1 and 10, and the biological significance of this small difference is questionable. Collectively, the data described above suggest that the HRG ligand present in the HI loop of the fiber in AdLuc(HRG-fiber) provided a novel CAR-independent, HER3/4-dependent cell entry pathway.
AdLuc(HRG-fiber) is equally or less susceptible to soluble knob competition, but more susceptible to HRG competition than AdLuc(wt-fiber) To investigate the contribution of the CAR binding portion of the fiber knob and the HRG EGF-like domain to transduction efficiency, three human cancer cell lines were treated with soluble wt fiber knob (s-knob) or recombinant HRG protein before infection with AdLuc(wt-fiber) or AdLuc(HRG-fiber) ( Figure 6 ). S-knob competition resulted in significant inhibition of AdLuc(wtfiber)-mediated reporter gene expression only in cells that expressed moderate to high levels of CAR (MDA-MB-468 and MDA-MB-231) (Po0.01, ANOVA), suggesting that s-knob blocked CAR-mediated entry into target cells, as expected. S-knob had an inhibitory effect on AdLuc(HRG-fiber)-mediated luciferase expression in the same cell lines, indicating that AdLuc(HRG-fiber) retained the ability to utilize the native fiber-CAR entry mechanism in CAR-expressing cells.
Competition experiments with recombinant HRG were carried out to assess the involvement of the HRG insert in AdLuc(HRGfiber) entry into these cancer cells (Figure 6 ). Although Fiber modification of adenovirus increases infection SH MacLeod et al recombinant HRG had no effect on AdLuc(wt-fiber)-mediated reporter gene expression, it significantly reduced AdLuc(HRGfiber)-mediated gene transfer in the cells that have detectable HER3/4 receptors (Figures 4a), suggesting that AdLuc(HRG-fiber) was able to enter cells in a CAR-independent manner, mediated by HRG-HER3/4 interactions. There was even some inhibition of AdLuc(HRG-fiber)-mediated gene transfer in the HER3/4 low cell line MDA-MB-231, which suggests that even a small amount of HER3 may be able to mediate increased gene expression after AdLuc(HRG-fiber) infection.
Competition by a combination of s-knob and recombinant HRG did not appear to increase inhibition of reporter gene expression in any of the cell lines beyond what was achieved by either inhibitor alone. This result was not expected for MDA-MB-468 cells that have high levels of both receptors, and suggests that interactions additional to CAR and HER3/4 binding may be important for the uptake of AdLuc(HRG-fiber) by those cells.
HRG modification of fiber facilitates infection of HER3-expressing CHO cells that are refractory to infection by virus with wt fiber As previously noted, infectivity can be dependent on factors additional to receptor levels. Thus, we wanted to examine Ad-delivered reporter gene expression in isogenic cell lines that differed only in receptor expression. Previously, Bergelson et al. 8 demonstrated that a control CHO cell line stably expressing a2 integrin is refractory to wt Ad5 infection, whereas CAR-expressing CHO cells are susceptible. 8 Therefore, we used Bergelson's control cells to generate a stable cell line that expressed moderate levels of HER3 (Figure 4b) , and compared infectivity of these cells to CHO cells with and without CAR overexpression (Figures 7a and b) .
As expected, expression of luciferase after AdLuc(wt-fiber) infection was significantly higher in CHO-CAR cells than in CHO cells lacking CAR (Figure 7a ). Reporter gene expression in AdLuc(HRG-fiber)-infected CHO-CAR cells was similar to that in infections with AdLuc(wt-fiber) (Figure 7b) . Furthermore, as predicted, HER3-expressing CHO cells (CHO-al2/HER3) supported AdLuc(HRG-fiber) infection, with reporter gene expression levels similar to that in CHO-CAR. Surprisingly, AdLuc(HRG-fiber) also infected cells expressing neither HER3 nor CAR, albeit with luciferase levels significantly less than that observed in infections of CHO-CAR or CHO-al2/HER3. Reporter gene expression in all CAR-negative CHO cell lines was significantly higher after AdLuc(HRG-fiber) infection than after AdLuc(wt-fiber) infection (Figures 7a and b) .
If AdLuc(HRG-fiber) infection of CAR-negative CHO cell lines were dependent on specific interactions between the HRG insert in fiber and receptors on the cell surface, one would predict that preincubation with recombinant HRG would block virus infection. When this was tested, we observed a significant decrease in reporter gene expression in both CHO-al2/HER3 and control CHOal2 cell lines (Figure 7c ). It is possible that uptake by human HER3-negative CHO cells is mediated by hamster receptors that bind HRG. However, as we did not see significant inhibition of infection of CHO-NT cells by HRG, we hypothesize that AdLuc(HRG-fiber) may interact with CHO cells in a manner that is not solely dependent on HRG-mediated interactions. This interaction appears to be specific to AdLuc(HRG-fiber), as AdLuc(wt-fiber) showed poor gene transfer to CAR-negative CHO cell lines (Figure 7a ). In addition, competition with HRG did not decrease reporter gene expression in CAR-negative cell lines after AdLuc(wt-fiber) infection (infection of CHO-al2/HER3 is shown in Figure 7c ).
These studies demonstrate that the addition of HRG to the HI loop allows the modified virus to enter cells that are refractory to infection by virus with wt fiber. This entry appears to be at least partially dependent on human HER3/4 interactions with the modified virus.
Reporter gene expression after intratumoral injection of AdLuc(HRG-fiber) in vivo is not increased when compared with that following injection with AdLuc(wt-fiber) A ZR-75-1 xenograft tumor model was used to assess in vivo gene transfer by the two viruses. Reporter gene expression in all virusinfected tumors was much higher than that in the uninjected contralateral tumors or in the livers (not shown). However, the two viruses were similar in their abilities to mediate gene transfer to the xenografted tumors (Figure 8 ), in contrast to our observations with in vitro cultured breast cancer cells.
DISCUSSION
A substantial effort has been invested in targeting Ad vectors by ablating the native tropism of Ad and providing alternate, tissuespecific targeting ligands. 25 The use of bispecific molecules that act as bridges between virions and target cells [67] [68] [69] [70] has been limited because of the instability of the virion-ligand complex in vivo. This can be avoided by genetic approaches that incorporate targeting peptides into viral capsid components, including the fiber, hexon and pIX proteins. 31, 32, 37, [70] [71] [72] [73] [74] [75] [76] Targeting ligands fused to hexon and pIX proteins are incorporated near the faces of the capsid rather than on the protruding fiber, which may reduce their ability to interact with cell surface receptors. However, Poulin et al. 77 recently constructed a genetic fusion of pIX with a single-domain antibody against CD66c, which enhanced vector targeting to CD66c-positive cells, demonstrating that pIX may be a good target for large genetic modifications. Although ligands fused to the C terminus of the fiber molecule can physically interact with cognate cellular receptors, the C terminus of fiber can only accommodate ligands up to 30 aa in size, other than the non-structured biotin acceptor protein. 75, 78, 79 Alternatively, small ligands such as FLAG, RGD, polylysine and transferrin receptor binding peptides can be incorporated into the highly flexible HI loop of fiber. [31] [32] [33] [34] Belousova and co-workers 37 have recently demonstrated the capacity of the HI loop to accommodate large (480 aa) targeting ligands by successfully generating infectious virions containing fragments of the penton base RGD loop inserted into the HI loop. Their data clearly show that the inserted fragments were capable of mediating a novel CAR-independent, integrin-dependent entry pathway; however, the ligand chosen was relatively nonstructured and as such did not address the issue of possible ligand-fiber structural incompatibilities. 37, 80, 81 Those authors were unsuccessful in an attempt to target Ad by inserting the highly structured 31 aa vasoactive intestinal peptide into the HI loop. In contrast, in our studies we inserted a highly structured 68 aa residue insertion, consisting of the EGF-like domain of HRG and linker sequences, into the HI loop of fiber. To our knowledge, this insertion is the largest functional, structured ligand to be rescued into the HI loop thus far.
The choice of the EGF-like domain of HRG as the targeting ligand stems, in part, from its ability to target retroviral particles 55 and fused polypeptides 82 to cells expressing its cognate receptors, HER3 and HER4. In addition, because the HER3 and HER4 receptors are frequently over-represented in some cancers, [52] [53] [54] an Ad with HRG-mediated expanded tropism may have potential therapeutic value.
Our data clearly show that insertion of HRG into the HI loop of Ad5 fiber had no detectable adverse effects on the fiber's ability to form trimers in vitro or assemble into virions with wt growth characteristics. Importantly, virions bearing HRG-modified fiber showed a significant receptor-dependent increase in transduction efficiency relative to wt fiber bearing virions. Moreover, virions containing HRG-modified fiber are less sensitive to soluble knob protein competition, suggesting that, in addition to the native fiber/CAR entry pathway, the modified virus was able to utilize a novel CAR-independent pathway. The involvement of the HRG ligand in this novel pathway was confirmed by the observation that recombinant HRG protein significantly inhibited modified virus-mediated reporter gene expression while having no effect on that mediated by wt virus. Furthermore, the increase in reporter gene expression is unlikely to be due to effects mediated by the binding of HRG to HER3/4, such as promoter activation, as this effect was not seen with the addition of HRG to wt virus infection.
HRG has recently been shown to bind to integrins, specifically a v b 3 and a 6 b 4 ; 83 however, its binding to HER3 is over 70-fold stronger, 84 suggesting that even though the HRG-modified virus may bind to integrins, the more relevant receptor for viral uptake is likely HER3/4. Integrin binding by HRG may have a role in activation of HER3; 83 however, the requirement for HER3 activation in viral uptake is not known at this time, and will be examined in future studies.
Unexpectedly, the higher in vitro infectivity of cells expressing high levels of HER3/4 seen with the fiber-modified virus, as Fiber modification of adenovirus increases infection SH MacLeod et al compared with the wt binding virus, did not translate to the mouse xenograft model. This may be due, in part, to decreased dispersion of the virus after intratumoral injection due to the high pressure of the tumor. 85 The virus was likely concentrated at the injection site, and could not spread to other parts of the tumor. We hypothesize that high concentration of virus at the injection site allowed uptake of the virus by low levels of CAR, masking HER3-mediated uptake. We propose that improving the dispersion of the virus within the tumor will recapitulate the increased infectivity of the modified virus in vitro. This may be addressed by two potential strategies. Firstly, the use of an oncolytic Ad, as opposed to the non-replicating vector used in these studies, should increase virus spread throughout the tumor via multiple rounds of viral replication. Thus, although the virus injected directly into the tumor may be taken up by both CAR and HER3 receptors, later rounds of replication could result in lower local viral concentrations and uptake with higher dependence on HER3 expression. Secondly, it may be more appropriate to choose a HER3/4-positive tumor target located in the peritoneal cavity, which may allow greater diffusion of the virus following intraperitoneal injection. A compelling target may be ovarian cancer, shown to overexpress these receptors, 86 and to form tumors in the peritoneal cavity. 87, 88 In addition, mouse tumor models for ovarian cancer are available and have been used previously to assess Ad vectors 89, 90 One reason for previous failure of Ad trials in ovarian tumors is low or variable CAR levels, 88, 89, 91 which the retargeted virus may be able to overcome.
Taken together, the data presented here demonstrate the ability of the fiber HI loop to accommodate a relatively large and structured ligand. This may ultimately lead to the expansion of the repertoire of ligands that can be used to modify viral tropism to generate Ad vectors with better therapeutic indices. Furthermore, combining HI loop modifications with previously defined mutations that ablate knob-CAR interactions 92, 93 should allow complete retargeting of the Ad virion.
